Get in touch.

List of contacts

Do you have any questions about ZB MED`s services or the range of literature we offer? Or maybe you need some tips on how to run searches in LIVIVO?

Contact

info@zbmed.de
Phone: +49 (0)221 999 892 240

Cologne Site

Medicine and Health

Address:
ZB MED – Information Centre for Life Sciences
Gleueler Straße 60
50931 Cologne (Köln)
Germany

Bonn Site

Nutritional, Environmental and Agricultural Sciences

Address:
ZB MED – Information Centre for Life Sciences
Friedrich-Hirzebruch-Allee 4
53115 Bonn
Germany

InfoCenter

INFORMATION.

KNOWLEDGE.
LIFE.

An infrastructure and research centre for data and information in the life sciences.

Studying or working in life sciences?

We've got the research tools you need.

Conference detail

Conference details

19.03.2018 - 20.03.2018

20th Annual Superbugs and Superdrugs

Location
Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY
Contact

Teri Arri,

tarri@smi-online.co.uk,

+4402078276000

Country
United Kingdom
Subject area(s)
Shortinfo

Providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities, SMi presents the established 20th annual Superbugs & Superdrugs conference which will return to Central London on 19th and 20th March 2018.


The threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered through powerful keynote addresses delivered by an expert panel of scientific leaders, drug discovery specialists and government bodies such as MHRA and DNDi.


SPEAKERS INCLUDE:


- Richard Bax, Senior Partner, TranScrip Partners

- Lloyd Czaplewski, Dir, Chemical Biology Ventures

- Mair Powell, Senior Clinical Assessor, MHRA

- Jean-Pierre Paccaud, Dir of Business Development at GARDP, Drugs for Neglected Diseases initiative (DNDi)

- Conrad Lichtenstein, CSO, Nemesis Bioscience

- David Brown, MD & Founder, Alchemy Biomedical Consulting

- Domingo Gargallo-Viola, CSO, ABAC Therapeutics

- John George, CSO, Oppilotech

- Larry Sutton, Scientific Founder, Gladius Pharmaceuticals

- Kathy Talkington, Project Dir, Pew Charitable Trusts

- David Cook, CSO, Blueberry Therapeutics

- William Weiss, Dir of Pre-Clinical Services, UNT Health Science Center

- Cara Cassino, CMO, ContraFect

- Stephen Barat, Head of Pre-Clinical & Early Clinical Development, SCYNEXIS


AGENDA HIGHLIGHTS:


- Analyze the current status of antimicrobial resistance with industry led insight into current strategies to tackle AMR

- Hear exclusive case studies from a selection of pharmaceutical companies on clinical progress

- Learn about regulatory pathways for the registration of new antimicrobial agents

- Evaluate the latest incentives and funding solutions to spur drug discovery

- Explore novel alternatives to antibiotics currently in development


Early birds available online